BioWorld MedTech

Jan. 11, 2016

View Archived Issues

Diabetic Foot Ulcer Market: Omnigraft approval seen as catalyst for Integra, DFU market

A new FDA approval is expected to be an important catalyst for Integra Lifesciences Corp. (Plainsboro, N.J.) and represents a step in the right direction for the broader diabetic foot ulcer (DFU) market. Read More

Inside the Beltway: Hatch, Wyden urge CMS to redo PAMA reporting mandates

Read More

Call Me Maybe: Cardiac variants fail to predict risk in prospective study

Read More

TAVR provides fertile market for firm: Vivasure Medical picks up CE mark for percutaneous vascular closure device

Read More

MDD's Company Stock Report

Read More

Opponents say not a wise move: Indian government urged to rethink health care price caps

Read More

Daily M&A: S&N completes acquisition of Blue Belt Holdings for $275M

Read More

Patent Watch: Biomarker Strategies gains key patents for core technology

Read More

Products

Read More

People in Places

Read More

MDD's Neurology Extra

Read More